South America Preclinical CRO Market

ID: MRFR/HS/47588-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
South America Preclinical CRO Market Research Report By Service Type (Biologics Testing, Small Molecule Testing, Toxicology Testing, Pharmacology Testing), By Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases), By Validation Type (In Vivo Studies, In Vitro Studies, Comparative Studies, Regulatory Studies), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Research Organizations) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035
South America Preclinical CRO Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.81%
2024 Market Size$ 525.6 Million
2025 Market Size$ 556.14 Million
2035 Market Size$ 978.51 Million
Key Players
Charles River Laboratories
Covance
PRA Health Sciences
Eurofins Scientific
Medpace
Wuxi AppTec
Trends
  • Rising Demand for Outsourced Services
  • Technological Advancements
  • Focus on Personalized Medicine
Opportunities
  • Growing Pharmaceutical Industry
  • Rising Focus on Innovative Therapies
  • Increasing Investment in Biotechnology
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Toxicology Testing
      2. 4.1.2 Pharmacokinetics
      3. 4.1.3 Pharmacodynamics
      4. 4.1.4 Safety Assessment
    2. 4.2 Healthcare, BY Service Type (USD Billion)
      1. 4.2.1 In Vivo Services
      2. 4.2.2 In Vitro Services
      3. 4.2.3 Bioanalytical Services
      4. 4.2.4 Regulatory Services
    3. 4.3 Healthcare, BY Therapeutic Area (USD Billion)
      1. 4.3.1 Oncology
      2. 4.3.2 Cardiovascular
      3. 4.3.3 Neurology
      4. 4.3.4 Infectious Diseases
    4. 4.4 Healthcare, BY Study Design (USD Billion)
      1. 4.4.1 Single Dose Studies
      2. 4.4.2 Multiple Dose Studies
      3. 4.4.3 Dose Escalation Studies
      4. 4.4.4 Long-Term Studies
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Charles River Laboratories (BR)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Covance (BR)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Eurofins Scientific (BR)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 PRA Health Sciences (BR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Wuxi AppTec (BR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Syneos Health (BR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Medpace (BR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 KCR (BR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY STUDY DESIGN
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    14. 6.14 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
    16. 6.16 HEALTHCARE, BY THERAPEUTIC AREA, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
    18. 6.18 HEALTHCARE, BY STUDY DESIGN, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY STUDY DESIGN, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
      2. 7.2.2 BY SERVICE TYPE, 2026-2035 (USD Billion)
      3. 7.2.3 BY THERAPEUTIC AREA, 2026-2035 (USD Billion)
      4. 7.2.4 BY STUDY DESIGN, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America South America Preclinical CRO Market Segmentation

South America Preclinical CRO Market By Application (USD Billion, 2022-2035)

  • Toxicology Testing
  • Pharmacokinetics
  • Pharmacodynamics
  • Safety Assessment

South America Preclinical CRO Market By South America Preclinical CRO Market Type (USD Billion, 2022-2035)

  • In Vivo South America Preclinical CRO Markets
  • In Vitro South America Preclinical CRO Markets
  • Bioanalytical South America Preclinical CRO Markets
  • Regulatory South America Preclinical CRO Markets

South America Preclinical CRO Market By Therapeutic Area (USD Billion, 2022-2035)

  • Oncology
  • Cardiovascular
  • Neurology
  • Infectious Diseases

South America Preclinical CRO Market By Study Design (USD Billion, 2022-2035)

  • Single Dose Studies
  • Multiple Dose Studies
  • Dose Escalation Studies
  • Long-Term Studies

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.